TY - JOUR
T1 - Convergence and reorientation via open innovation
T2 - The emergence of nutraceuticals
AU - Siedlok, Frank
AU - Smart, Palie
AU - Gupta, Abhishek
N1 - Funding Information:
This research was funded by the ESPRC, UK Biobank and IBM Business Consulting services. The interpretations and conclusions in this paper are the authors’ and do not necessarily represent the funding organisations. An earlier version of this paper was presented at the British Academy of Management.
Funding Information:
Palie Smart’s research focuses on the topics of strategic innovation management practice, culture of innovation, leadership for innovation and innovation networks. She was awarded a grant from the EPSRC to investigate the role of innovation networks in the drug development process, with the lead industrial collaborator being IBM Business Consulting Services. Her public research portfolio includes eight joint EPSRC and industry funded research grants since the mid 1990s, investigating the management and organisational issues associated with new product development in Europe, USA and Japan. Recently she has received two EPSRC ICASE awards in ‘Open Innovation’.
Funding Information:
Frank Siedlok’s doctoral research is on communities of practice and interdisciplinary research collaborations, but his interests also include industrial clusters and collaborative innovation. He is currently working as a research fellow at Strathclyde University on multidisciplinary project funded by EPSRC, which aims to stimulate interdisciplinary collaboration. Prior to that Frank worked at Durham University on EU funded research project on emergence of industrial clusters, resulting in establishment of Subsea NorthEast.
PY - 2010/7
Y1 - 2010/7
N2 - The use of networked organisational arrangements to conduct exchanges is one of the most distinctive features of high-tech research-intensive industries. Advances in biotechnology and genomics research have enabled a generic technology platform that has fuelled a more 'open' approach to innovation and learning. This relies on collaborations between networked partners and allows for the convergence and reorientation of traditional sectors. This paper lends support to the view that some technologies can trigger a higher system level innovation, that is, in addition to the inter-firm level, an inter-industrial and inter-institutional level convergence and re-orientation process. This paper explores how this phenomenon is being witnessed in the pharmaceutical and food sectors and fast becoming a dominant logic in the emerging nutraceuticals industry.
AB - The use of networked organisational arrangements to conduct exchanges is one of the most distinctive features of high-tech research-intensive industries. Advances in biotechnology and genomics research have enabled a generic technology platform that has fuelled a more 'open' approach to innovation and learning. This relies on collaborations between networked partners and allows for the convergence and reorientation of traditional sectors. This paper lends support to the view that some technologies can trigger a higher system level innovation, that is, in addition to the inter-firm level, an inter-industrial and inter-institutional level convergence and re-orientation process. This paper explores how this phenomenon is being witnessed in the pharmaceutical and food sectors and fast becoming a dominant logic in the emerging nutraceuticals industry.
KW - Innovation strategy
KW - Knowledge management
KW - New product development
KW - Pharmaceutical industry
KW - Technology and innovation studies
KW - Technology management
UR - http://www.scopus.com/inward/record.url?scp=77953672145&partnerID=8YFLogxK
U2 - 10.1080/09537325.2010.488062
DO - 10.1080/09537325.2010.488062
M3 - Article
AN - SCOPUS:77953672145
SN - 0953-7325
VL - 22
SP - 571
EP - 592
JO - Technology Analysis & Strategic Management
JF - Technology Analysis & Strategic Management
IS - 5
ER -
